Resume **/**/****

Frank A. Eldredge, Ph.D.

*** **** *** ***** **** B

Springville, UT 84663

cell: 435-***-****

Email: ad27k1@r.postjobfree.com

Preface:

Dr. Eldredge has been engaged in several areas of excellence and expertise in the past. He is experienced in administration, teaching, QA/RA and applied laboratory research projects including basic research, proof of principle and production of prototypes.

Employment Experience:

June 5, 2018 – October 3, 2018

He and his spouse travelled by invitation to Stockholm Sweden to perform humanitarian services under direction of their leadership. (Dr Eldredge and spouse are fluent in the Swedish language).

July 10,2017 – May 31, 2018

Was the Scientist in Residence at Ballard Mfg., Inc. acting as coworker and advisor to the CEO, Mr. Frank Ballard, PhD.

January 2013- June 2017

Was semi-retired; nevertheless, was available for small projects as needed.

November, 2008 – November, 2012.

He was recently assigned as the Environmental Officer functioning as an environmental applied scientist for Deseret Laboratories, Inc. (DLI). Previous to that assignment, Dr. Eldredge has served as the full-time Regulatory Affairs Mgr. and in the QA Dept. with DLI, St. George, UT 84790 from Nov., 2008 until Feb. 30, 2012. His functions at DLI were many and varied. He has acted as liaison with U.S. regulatory agencies.

August, 2004 – October, 2008 Sr. Scientist, Lab Director, and Project Mgr with VSG (now DxNA, LLC), St. George, Utah, Full time.

Dr. Eldredge was the Senior Research Scientist with Venture Solutions Group (VSG)- (now DxNA, LLC)

He is a direct participant in the discovery and development of revolutionary new rapid PCR detection system for pathogenic organisms. This new system for performing polymerase chain reaction (PCR) is rapid, specific and sensitive.

Jan. 30, 2001 – July, 2004: Consulting Scientist in Applied Sciences to Industry-

January, 2002 to June, 2004:

Worked with Histatek, Inc (Phoenix) – a small biotech with a specialty in anti-inflammatory drugs. Also, worked with private development groups (confidentiality considerations in place).(Alpha & Omega Engineering; Laundrox Inc.; Enercon Engineering, etc. and more).

April 1, 2001 November, 2001:

Contract with CoorsTek - Oklahoma City, OK working with purification and disinfection technologies for protection against pathogens often found in water, and foodstuffs and impacts upon the QA/QC of the pharmaceutical industry.

March 3, 1997 - Dec., 2000:

Purizer Corp. (formerly Bioxide Corp.)

Midvale, Utah - (later Oakbrook, IL)

Chief Scientist and Director of Res. & Dev.

Proj. Mgr. for development project - Deligen II process (Now the

Purizer vapor).

Part of team that formed an Agreement with Battelle Memorial Institute, Columbus, Ohio.

Dr. Eldredge took the proposed discovery of Purizer technology and performed the proof of principle. He designed the first three prototypes and proved the reality of the Deligen II gases (now called the Purizer Vapor). He successfully applied the principle to water and disinfection and also turned pure water into a high level disinfectant in and of itself. His development allowed Bioxide Corp (now Purizer Corp.) to bring the process to Battelle Memorial Institute for a more complete and advanced development of the process, preparatory to entering the marketplace.

Problem Needing a Solution -

An acquired process was sold to Bioxide Corp. (later called Purizer Corp.) The basic idea required some research to attain proof-of-principle. The President of Bioxide assigned me to plan and execute a research protocol that could determine the feasibility of using the proposed process to effect disinfection, purification and/or environmental remediation.

Solution to the Problem:

Dr. Eldredge transformed an extra room into a research laboratory. He devised the necessary protocol to investigate the efficacy and feasibility of the acquired process. He enlisted the cooperation of a regional laboratory to provide the needed test bio-organisms. Dr. Eldredge followed the testing protocol to determine the effectiveness of the process. A series of experiments were performed and data collected. The data was used as a guide to proceed with the application of the main protocol. It was possible to adjust the application of the process and the underlying condition to arrive at a very successful and applicable outcome. This outcome was proven both repeatable and reliable.

Outcome of solving the problem:

The firm was able to present the results and supporting data to a well-known national research lab group. The national lab was impressed with the presentation to the extent that they formed an alliance with the firm. This was the direct result of his Research and Presentation.

March 3, 1997 - Sept. 30, 1997

Worked for Purizer Corp (Bioxide) and Biomune Systems, Inc. concurrently as half-time employee for each company respectively. Became full-time employee at Bioxide Corp. on October 1, 1997. Was the Proj. Mgr. for the main development project of Deligen II Process event.

April 15, 1993 - Sept. 30, 1997

Biomune Systems, Inc.

Executive Vice President for New Product Development

Project manager for preclinical research endeavors.

Also, a member of RA/QA team that successfully submitted two drug IND's to Biologics at the F.D.A.

He obtained an orphan drug designation for Biomune from the F.D.A. for the first drug indication.

Participated in 1st Phase Human clinical Trials for first indication which consisted of use of an Advanced Biologic Material proven to be effective against C. parvum which causes fatal Cryptosporidial wasting in patients with active AIDS. The trials were held at St. Luke’s - Roosevelt Hospital in New York City.

Managed research and development project mgr. for the preclinical portion of the IND’s.

Supported and gave input to intellectual property filings.

January 1980 - March 1992:

President of ERI. A firm importing OTC equipment and configuring the same for USA OTC device markets.

August, 1972 - December, 1979:

Associate Professor (tenured) Biology Dept., Central Michigan University

Educator and Researcher--

Associate Professor (tenured) of Biology, Central Michigan University, 1975-79.

Assistant Prof. of Biology, Central Michigan University, 1972-75; Tenured, 1975.

Member of Team teaching and producing the MS Degree in Electron Microscopy.

Teaching Associate, Dept. of Biology, Univ. of Utah, 1971.

Genetics Labs Teaching Assistant, Dept of Biology, Univ. of Utah, 1966-68.

Special Assignments:

Member of the University Faculty Grievance Review Committee, Central Michigan University.

Member of the Research & Creative Endeavors Committee, Central Michigan University.

Member of various faculty search committees to fill vacancies in the Biology Dept., Central Michigan University.

Functioned as student counselor for the K-12 Education minors in Biology, Central Michigan University.

Member of Graduate Council in the Dept. of Biology, Univ. of Utah.

Education:

University of Utah BA in Biology. Dept. of Molecular & Genetic Biology.

Univ. of Utah MS Genetics Major and Botany Minor, Dept. of Biology.

Univ. of Utah Ph.D. Genetics plus Allied Fields, Dept. of Biology.

Contact this candidate